NO20030052L - Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer - Google Patents

Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer

Info

Publication number
NO20030052L
NO20030052L NO20030052A NO20030052A NO20030052L NO 20030052 L NO20030052 L NO 20030052L NO 20030052 A NO20030052 A NO 20030052A NO 20030052 A NO20030052 A NO 20030052A NO 20030052 L NO20030052 L NO 20030052L
Authority
NO
Norway
Prior art keywords
msi
tumors
genes
gene products
products relevant
Prior art date
Application number
NO20030052A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030052D0 (no
Inventor
Peer Bork
Yan Ping Yuan
Johannes Gebert
Stefan Woerner
Michael Linnebacher
Original Assignee
Doeberitz Magnus Von Knebel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doeberitz Magnus Von Knebel filed Critical Doeberitz Magnus Von Knebel
Publication of NO20030052D0 publication Critical patent/NO20030052D0/no
Publication of NO20030052L publication Critical patent/NO20030052L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20030052A 2000-07-07 2003-01-06 Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer NO20030052L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10032608A DE10032608A1 (de) 2000-07-07 2000-07-07 Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte
PCT/DE2001/002510 WO2002004664A2 (de) 2000-07-07 2001-07-04 Aus tumorzellen isolierbare gene mit kodierenden mononucleotid- oder dinucleotid-mikrosatelliten

Publications (2)

Publication Number Publication Date
NO20030052D0 NO20030052D0 (no) 2003-01-06
NO20030052L true NO20030052L (no) 2003-03-07

Family

ID=7647836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030052A NO20030052L (no) 2000-07-07 2003-01-06 Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer

Country Status (8)

Country Link
US (1) US20040265803A1 (https=)
EP (1) EP1352088A2 (https=)
JP (1) JP2004512021A (https=)
AU (1) AU2001281708A1 (https=)
CA (1) CA2415199A1 (https=)
DE (1) DE10032608A1 (https=)
NO (1) NO20030052L (https=)
WO (1) WO2002004664A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361286A1 (en) * 2002-04-18 2003-11-12 MTM Laboratories AG Method for detection of cancer
AU2003232485A1 (en) 2002-04-18 2003-10-27 Mtm Laboratories Ag Neopeptides and methods useful for detection and treatment of cancer
EP1354895A1 (en) * 2002-04-18 2003-10-22 MTM Laboratories AG Neopeptides useful for detection and treatment of cancer
CA2651796A1 (en) * 2006-02-27 2007-09-07 Arizona Board Of Regents For And On Behalf Of Arizona State University Identification and use of novopeptides for the treatment of cancer
US9732131B2 (en) * 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
JP2019505512A (ja) 2016-01-08 2019-02-28 バッシボディ アクスイェ セルスカプ 治療用抗癌ネオエピトープワクチン
US20200276285A1 (en) 2017-06-02 2020-09-03 Arizona Board Of Regents On Behalf Of Arizona State University A method to create personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
EP4038222A4 (en) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
AU744157B2 (en) * 1997-07-28 2002-02-14 Fox Chase Cancer Center Novel gene encoding a DNA repair endonuclease and methods of use thereof
CA2417866A1 (en) * 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
NO20030052D0 (no) 2003-01-06
WO2002004664A3 (de) 2003-06-19
AU2001281708A1 (en) 2002-01-21
WO2002004664A2 (de) 2002-01-17
JP2004512021A (ja) 2004-04-22
CA2415199A1 (en) 2003-01-07
US20040265803A1 (en) 2004-12-30
WO2002004664A9 (de) 2002-09-19
DE10032608A1 (de) 2002-01-24
EP1352088A2 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
CY2016020I1 (el) Στελεχη ιου του ερπη για γονιδιακη θepαπεια
DK1221955T3 (da) Immunstimulerende nukleinsyre
AU2001255518A1 (en) Compositions and methods for array-based nucleic acid hybridization
AU6069300A (en) Novel human genes and gene expression products
NO20002849L (no) Sammensetninger og metoder for Õ indusere genekspersjon
NO983449L (no) Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi
EP1142591A4 (en) gene carriers
GB2406169B (en) Methods and compositions relating to labeled rna molecules that reduce gene expression
AU2001285047A1 (en) Human genes and gene expression products
EP1339875A4 (en) COMPOSITIONS AND METHOD FOR THE FAST PRODUCTION OF RECOMBINANT NUCLEIC ACID MOLECULES
NO20030052D0 (no) Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer
AU7333701A (en) Chromosome 3p21.3 genes are tumor suppressors
EP1490074A4 (en) MIXED CELLULAR GENE THERAPY
ATE384118T1 (de) Gene von felincalizivirus und impstoffe, die diese gene enthalten
IL153388A0 (en) Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
DE60142519D1 (de) Dna-expressionsvektoren
NO20033624D0 (no) Matrise genekspresjon i chondrogenese
NO20013102L (no) Gener, proteiner og deres anvendelse
AU2002327607A8 (en) Human genes and gene expression products isolated from human prostate
NO20030963D0 (no) Metanotrofe karbon metabolisme-pathway-gener og enzymer
EP1239042A4 (en) TRANSPOSASE AND METHOD FOR GENE MODIFICATION
EP1434875A4 (en) GENE POLYMORPHISMS AND TREATMENT RESPONSE
EP1174499A4 (en) NEW AMIDASEGENE
DE60118681D1 (de) Testis-spezifisches Gen
GB9906018D0 (en) Expression of DNA or proteins in C.elegans